Hearing the words “stage 4 cancer” can feel overwhelming—but stage 4 does not automatically mean terminal. Thanks to advances in immunotherapy, targeted therapy, radiation, and multidisciplinary care, many metastatic cancers are now treatable for years. In this expert guide, Dr. Matthew Meranda explains what stage 4 cancer really means, how it is treated, how prognosis is discussed, and practical ways patients and families can navigate difficult conversations while maintaining quality of life.

Stage 4 cancer is serious, but it is not the harbinger of death it once was. While any cancer diagnosis is devastating, this term “stage 4” seems to have its own terrible weight, like a stone, which is carried around by patients and their families. But “stage 4” and “terminal” are not the same. Stage 4 cancer is indeed the most severe form of disease, but this does not give credit to the incredible advancements made in cancer medicine nearly every day. Targeted- and immuno-therapies alongside precise radiotherapy and advanced surgical techniques have prolonged survival for all patients with cancer, including those with stage 4 diseases.

Here, we will talk about what makes a cancer “stage 4” and how cancers of this stage are treated. We will also dive into the challenge of how cancer doctors determine prognosis and offer some tips to improve communication between patients and providers throughout the cancer journey.

What Does It Mean to Be Diagnosed with Stage 4 Cancer?

Cancer is a disease in which abnormal cells grow uncontrollably; the more a cancer grows, the more harmful it becomes. Simply put, the cancer staging system can be thought of as describing how much a person’s cancer has grown. Cancer is staged 1 through 4 based on the tumor’s size, growth into adjacent tissues, and spread to other organs.

The label of “stage 4” describes cancer that has traveled beyond the organ in which it originated to grow in other, distant parts of the body. Cancers growing in these other parts of the body are known as “metastases” (plural) and are why stage 4 cancer is commonly referred to as “metastatic cancer”. In this way, stage 4 disease describes the behavior of a person’s cancer rather than a specific kind of cancer itself.

The bones, liver, and lungs are especially common places for cancer to spread. Cancer also frequently spreads to lymph nodes, collections of immune cells scattered throughout the body. Because of this spread, stage 4 cancer requires more aggressive treatment than cancer at lower stages.

There are some important exceptions to the cancer staging system to be aware of. For example, cancers of the blood and bone marrow, like leukemia, do not usually form masses or tumors that can be measured based on size. The different types of leukemia are instead “graded” based on a person’s symptoms and lab results. Lymphoma, a cancer of the lymphatic system and lymph nodes, is considered stage 4 only if cancer cells have exited the lymphatic system itself. Finally, cancers of the brain, spinal cord, or hormone-producing cells are also exceptions to the 1 through 4 staging system. It is important to talk with your cancer doctors about your specific diagnosis and how it is staged.

Treating stage 4 cancer

Once a cancer has reached stage 4 and has spread to other areas across the body, it is difficult to completely eradicate. This is because cancer, which has metastasized, can now travel throughout the body in the bloodstream or lymphatic system. These microscopic cells may not be visible on even the most advanced medical imaging, so simply removing the tumors large enough to see might not eliminate every dangerous cell. Moreover, cancer that has metastasized can be expected to behave more aggressively and be more resistant to treatment. This is why systemic treatments such as chemotherapy, immunotherapy, and other precision medicines are essential to the management of advanced cancers.

While stage 4 cancer may not be outright curable (i.e., complete eradication from the body without the chance of recurrence), it is often quite treatable. In fact, treatment options for patients with stage 4 cancers have expanded significantly in recent years, helping patients to live longer and with a better quality of life.

As the treatment for specific cancers varies widely, there are some core principles to know when discussing options with your oncology team.

First, metastatic cancers are named for the place they initially emerged (e.g., stage 4 breast cancer with metastasis to the lungs), because the organ a cancer originally grew from determines its treatment.

Second, it is helpful to know that the treatment of stage 4 cancer focuses on control of the disease rather than elimination. Ultimately, cancer doctors will offer treatments that decrease as much of the disease around the body as possible while managing the difficult side effects of those treatments. The goal of treating stage 4 cancer is to maximize quality of life, knowing that a cure might not be possible. Maintaining the balance between the effectiveness and toxicity of treatment is the main challenge of managing advanced-stage cancer.

In general, the most intensive treatments will be given first to maximize early disease control. Such treatments may be considered unsafe, however, for patients who are sicker before the start of systemic therapy; aggressive chemotherapy may not be suitable for older or frailer patients if there is a chance that treatment side effects might make them even sicker. For such patients, gentler treatment options with fewer toxic agents may be chosen, and lengthy infusions of anti-cancer medicine may be substituted for pill-form medications, which can be taken at home.

Regardless of the patient or the cancer type, the management of advanced-stage disease takes a team. Surgical, medical, and radiation oncologists are all frequently consulted to provide a multidisciplinary approach to cancer treatment. The roles of social workers, nurse navigators, counselors, and symptom management specialists are also critically important.

Finally, it is important to know that not all metastatic cancers are the same. If a person's cancer has only spread to a few other places—generally one or two other organs—then it is referred to as “oligometastatic”. Recent studies have shown that using radiation or surgery to remove the largest, most dangerous collections of cancer cells in oligometastatic cancer can significantly prolong survival. In short, outcomes for stage 4 cancer can vary widely, and it is vital to talk with your cancer team about your specific treatment options and prognosis.

How to Navigate Difficult Conversations with Stage 4 Cancer: 3 Practical Tips

This all brings us to the discussion of communication. Unfortunately, doctors and patients frequently miscommunicate about cancer prognosis. Not only is determining life expectancy a huge challenge. Studies have shown that cancer doctors may sometimes incorrectly predict the outcome of the disease. As such, they may be as reluctant to talk about death as patients are to hear about it.

Here are some tips to get the most out of each visit with your cancer teams:

1. Bring loved ones to your appointments

Poor communication between doctors and patients — whether about big or small concerns — can lead to misunderstanding. While some miscommunication is expected, it is more likely when news is complicated or emotionally charged, and discussions of cancer diagnosis, management, and prognosis fit squarely into this category. In these conversations, it’s helpful to have another set of ears: if possible, try to bring a friend or family member to your appointments. Companions help us to see problems from alternate angles and to think of questions we might not realize we have. Sometimes, it’s not always possible to bring someone along to every visit. In this case, it can be helpful to ask for permission to record your conversations with your cancer team. There may be restrictions on recording depending on your treating institution (often, these restrictions are in place in order to protect patient privacy when sensitive health information is being shared), so be sure to always ask permission before recording.

2. Write your questions down

Your doctor should always ask what questions you have. This is not just a polite gesture. Your physicians genuinely want to know how they can communicate more clearly. These discussions can be overwhelming, and you might not have a question on hand; that’s okay! A helpful solution is to write questions down as they arise, whether before a visit, during, or after. Keep these questions somewhere consistent, like in a notebook with the rest of your medical paperwork or as a note-to-self on your smartphone. If the question is urgent, most medical systems have a virtual patient messaging platform to reach your medical team at any time. Otherwise, simply bring the questions along to your next visit.

3. Share what you know in your own words

Finally, the practice of “teach-back” is one of the best ways to ensure that your understanding of your medical information is accurate. Restate what you have just been told in your own words. This will provide an excellent opportunity for members of your cancer team to clarify any misconceptions. Remember, it takes years of training for cancer doctors, nurses, and social workers to know cancer as well as they do. You cannot be expected to share this same level of understanding straight away, especially in the context of life and death surrounding stage 4 cancer.

Living with Stage 4 Cancer: What to Expect and How to Cope

It is easy to feel hopeless with the diagnosis of stage 4 cancer, and it is normal to feel overwhelmed by the gauntlet of appointments, tests, and medical information that comes along with it. In many ways, the story of advanced cancer is not of either cure or of death, but rather, learning to live with the disease. Because promoting quality of life with stage 4 cancer is so important, it is also necessary to integrate supportive care services like palliative care early into the treatment journey, which you can read more about here.

There are many options for the treatment of stage 4 cancer, so what is most important is finding the right one for you. Along the way, clear conversations with your loved ones and medical team will help decide what this looks like. Being diagnosed with stage 4 cancer is incredibly challenging, but it does not mean the end is near. The treatment options are growing every day, so while learning to live alongside cancer, there is always a good reason to hope for a future without it.

About Author

Matthew Meranda, DO Fellow, Hospice and Palliative Medicine, University of Texas MD Anderson Cancer Center

Worked Discussed

Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025). Cancer statistics, 2025. CA: a cancer journal for clinicians, 75(1), 10–45.

“Stages” of Leukemia: Understanding Classification and Progression | Blood Cancer United. (2025). Bloodcancerunited.org. https://bloodcancerunited.org/resources/blog/stages-leukemia-understanding-classification-and-progression

International Myeloma Foundation. (2021, August 24). International Staging System (ISS) and Revised ISS (R-ISS). International Myeloma Foundation. https://www.myeloma.org/international-staging-system-iss-reivised-iss-r-iss

Lymphoma staging | Lymphoma Action. (2025). Lymphoma Action. https://lymphoma-action.org.uk/information-and-support/tests-scans-and-lymphoma-staging/lymphoma-staging

Vollmering, K. (2023, March 13). Oligometastatic cancer: What patients with stage IV cancer should know. MD Anderson Cancer Center. https://www.mdanderson.org/cancerwise/what-is-oligometastatic-cancer--what-patients-with-stage-iv-cancer-should-know.h00-159617067.html

Hui D. (2015). Prognostication of Survival in Patients With Advanced Cancer: Predicting the Unpredictable?. Cancer control : journal of the Moffitt Cancer Center, 22(4), 489–497.

Han, P. K., Dieckmann, N. F., Holt, C., Gutheil, C., & Peters, E. (2016). Factors Affecting Physicians' Intentions to Communicate Personalized Prognostic Information to Cancer Patients at the End of Life: An Experimental Vignette Study. Medical decision making : an international journal of the Society for Medical Decision Making, 36(6), 703–713.

Ho T, Campos BS, Tarn DM. Post-Visit Patient Understanding About Newly Prescribed Medications. J Gen Intern Med. 2021;36(11):3307-3310.

Yen, P. H., & Leasure, A. R. (2019). Use and Effectiveness of the Teach-Back Method in Patient Education and Health Outcomes. Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 36(6), 284–289.